A Phase I, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Tolerance of Oil Palm Phenolics (OPP) in Healthy Volunteers

Background and aim: Oil palm aqueous by-products rich in phenolic content are known as oil palm phenolics (OPP), and pre-clinical research has shown that OPP has great potential to be further developed as an anti-hyperlipidemic agent. Hence, in order to introduce OPP into market, its safety profile...

Descripción completa

Detalles Bibliográficos
Autores principales: Muhammad Ismail Tadj, Nur Balqis, Ibrahim, Nurul ‘Izzah, Haji Mohd Saad, Qodriyah, Tg Abu Bakar Sidik, Tg Mohd Ikhwan, Leow, Soon-Sen, Fairus, Syed, Naina Mohamed, Isa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251303/
https://www.ncbi.nlm.nih.gov/pubmed/35795564
http://dx.doi.org/10.3389/fphar.2022.893171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251303/
https://www.ncbi.nlm.nih.gov/pubmed/35795564
http://dx.doi.org/10.3389/fphar.2022.893171

Ejemplares similares